As a leading global research and development-based pharmaceutical company, Eisai conducts drug discovery and research activities by applying cutting-edge knowledge and technologies. We consider that drug discovery for neglected tropical diseases (NTDs), as well as malaria and tuberculosis where the need for new drug discovery remains high, are important R&D activities for improving access to medicines.
Research & Development Activities for the Improvement of Access to Medicines
-
Eisai’s Efforts on Global Health ― An Interview of Scientists Working on Drug DiscoveryAugust 25, 2023
-
A Scientist Developing New Antimalarial Drugs Talks About His Fight Against the Disease Prevalent Around the WorldApril 25, 2023
-
Trusting Relationships with Partners Hold the Key to NTDs Therapeutic Drug Development ー Mr. Tatsuro Kuzuki, DNDi JapanJanuary 27, 2023
-
Eisai’s CEO Naito Participated in Online Event “Deliver 18 new treatments by 2028 – The future of partnerships and role of Japan”July 20, 2021
-
Equipment Donation to Developing Countries ―The Initiative Selected as a Best Practice for R&D Capacity Building in the 2021 Access to Medicine IndexMarch 17, 2021
-
Eisai Participates in Launch of AMR Action Fund
—Partnership of More Than 20 Leading Pharmaceutical Companies Aims to Bring 2 to 4 New Antibiotics to Patients by 2030—July 10, 2020
Previous Articles
-
Joint Research Paper on Antimalarial Medicine by Broad Institute and Eisai Published in Nature
- A Report Shows New Step Forward for Development of New AntimalarialsFebruary 8, 2017
-
Development of a Treatment for Eumycetoma, One of the World's Most Neglected DiseasesJanuary 8, 2016
-
Implementing Compound Screening for NTD Drug DiscoveryJune 19, 2014
-
Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate infectious disease in developing countriesJuly 11, 2013
-
Message from the First TDR Fellow at Eisai
July 12, 2012
-
Boosting Research & Development into Neglected Tropical Disease Treatments
—Eisai Participates in WIPO-Sponsored Global Consortium for Open Innovation Partnerships—November 10, 2011
-
Eisai Takes Second Clinical Research Fellow From Developing World
June 29, 2011
-
Working together to treat Chagas Disease with new medicines
May 26, 2011
-
Working together to develop new and more effective vaccines
May 26, 2011
-
Working together to fight malaria with new medicines: Exploratory research targeting GWT1
May 26, 2011
-
Working together to fight malaria with new medicines: Development of an active Toll-like receptor (TLR) 9 antagonist
May 26, 2011
Our Activities
- Research & Development for Improving Access to Medicines